164 related articles for article (PubMed ID: 10821437)
1. 6-Hydroxydopamine toxicity towards human SH-SY5Y dopaminergic neuroblastoma cells: independent of mitochondrial energy metabolism.
Storch A; Kaftan A; Burkhardt K; Schwarz J
J Neural Transm (Vienna); 2000; 107(3):281-93. PubMed ID: 10821437
[TBL] [Abstract][Full Text] [Related]
2. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
[TBL] [Abstract][Full Text] [Related]
3. 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism.
Storch A; Kaftan A; Burkhardt K; Schwarz J
Brain Res; 2000 Feb; 855(1):67-75. PubMed ID: 10650131
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (Mpp+) towards dopaminergic mesencephalic neurones in primary culture.
Callier S; Le Saux M; Lhiaubet AM; Di Paolo T; Rostène W; Pelaprat D
J Neurochem; 2002 Jan; 80(2):307-16. PubMed ID: 11902121
[TBL] [Abstract][Full Text] [Related]
5. Effects of 6-hydroxydopamine on mitochondrial function and glutathione status in SH-SY5Y human neuroblastoma cells.
Tirmenstein MA; Hu CX; Scicchitano MS; Narayanan PK; McFarland DC; Thomas HC; Schwartz LW
Toxicol In Vitro; 2005 Jun; 19(4):471-9. PubMed ID: 15826805
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of riluzole on dopamine neurons: involvement of oxidative stress and cellular energy metabolism.
Storch A; Burkhardt K; Ludolph AC; Schwarz J
J Neurochem; 2000 Dec; 75(6):2259-69. PubMed ID: 11080177
[TBL] [Abstract][Full Text] [Related]
7. The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism.
Lannuzel A; Michel PP; Höglinger GU; Champy P; Jousset A; Medja F; Lombès A; Darios F; Gleye C; Laurens A; Hocquemiller R; Hirsch EC; Ruberg M
Neuroscience; 2003; 121(2):287-96. PubMed ID: 14521988
[TBL] [Abstract][Full Text] [Related]
8. The role of oxidative stress, impaired glycolysis and mitochondrial respiratory redox failure in the cytotoxic effects of 6-hydroxydopamine in vitro.
Mazzio EA; Reams RR; Soliman KF
Brain Res; 2004 Apr; 1004(1-2):29-44. PubMed ID: 15033417
[TBL] [Abstract][Full Text] [Related]
9. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons.
Lotharius J; Dugan LL; O'Malley KL
J Neurosci; 1999 Feb; 19(4):1284-93. PubMed ID: 9952406
[TBL] [Abstract][Full Text] [Related]
10. Functional GPR37 trafficking protects against toxicity induced by 6-OHDA, MPP+ or rotenone in a catecholaminergic cell line.
Lundius EG; Stroth N; Vukojević V; Terenius L; Svenningsson P
J Neurochem; 2013 Feb; 124(3):410-7. PubMed ID: 23121049
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic neurotoxicity by 6-OHDA and MPP+: differential requirement for neuronal cyclooxygenase activity.
Carrasco E; Casper D; Werner P
J Neurosci Res; 2005 Jul; 81(1):121-31. PubMed ID: 15931668
[TBL] [Abstract][Full Text] [Related]
12. RA410/Sly1 suppresses MPP+ and 6-hydroxydopamine-induced cell death in SH-SY5Y cells.
Bando Y; Katayama T; Taniguchi M; Ishibashi T; Matsuo N; Ogawa S; Tohyama M
Neurobiol Dis; 2005 Feb; 18(1):143-51. PubMed ID: 15649705
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of SCM198 on 6-hydroxydopamine-induced behavioral deficit in rats and cytotoxicity in neuronal SH-SY5Y cells.
Shi XR; Hong ZY; Liu HR; Zhang YC; Zhu YZ
Neurochem Int; 2011 Jul; 58(8):851-60. PubMed ID: 21093517
[TBL] [Abstract][Full Text] [Related]
14. The neuroprotective role of tissue inhibitor of metalloproteinase-2 in MPP+- or 6-OHDA-treated SK-N-BE(2)C and SH-SY5Y human neuroblastoma cells.
Kim SY; Woo MS; Park JS; Hyun JW; Kim YS; Kim HS
Neurosci Lett; 2010 Jan; 468(2):136-40. PubMed ID: 19883732
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of creatine against 6-hydroxydopamine-induced cell death in human neuroblastoma SH-SY5Y cells: Involvement of intracellular signaling pathways.
Cunha MP; Martín-de-Saavedra MD; Romero A; Parada E; Egea J; Del Barrio L; Rodrigues AL; López MG
Neuroscience; 2013 May; 238():185-94. PubMed ID: 23485810
[TBL] [Abstract][Full Text] [Related]
16. Baicalein attenuates 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells.
Lee HJ; Noh YH; Lee DY; Kim YS; Kim KY; Chung YH; Lee WB; Kim SS
Eur J Cell Biol; 2005 Nov; 84(11):897-905. PubMed ID: 16323286
[TBL] [Abstract][Full Text] [Related]
17. Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue.
Andres RH; Huber AW; Schlattner U; Pérez-Bouza A; Krebs SH; Seiler RW; Wallimann T; Widmer HR
Neuroscience; 2005; 133(3):701-13. PubMed ID: 15890457
[TBL] [Abstract][Full Text] [Related]
18. Dopamine induces TNFalpha and TNF-R1 expression in SH-SY5Y human neuroblastoma cells.
Gómez-Santos C; Francisco R; Giménez-Xavier P; Ambrosio S
Neuroreport; 2007 Oct; 18(16):1725-8. PubMed ID: 17921876
[TBL] [Abstract][Full Text] [Related]
19. Activation of NF-kappaB is involved in 6-hydroxydopamine-but not MPP+ -induced dopaminergic neuronal cell death: its potential role as a survival determinant.
Park SH; Choi WS; Yoon SY; Ahn YS; Oh YJ
Biochem Biophys Res Commun; 2004 Sep; 322(3):727-33. PubMed ID: 15336524
[TBL] [Abstract][Full Text] [Related]
20. Alterations in energy/redox metabolism induced by mitochondrial and environmental toxins: a specific role for glucose-6-phosphate-dehydrogenase and the pentose phosphate pathway in paraquat toxicity.
Lei S; Zavala-Flores L; Garcia-Garcia A; Nandakumar R; Huang Y; Madayiputhiya N; Stanton RC; Dodds ED; Powers R; Franco R
ACS Chem Biol; 2014 Sep; 9(9):2032-48. PubMed ID: 24937102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
